Attovia Therapeutics, Inc. ($ATTO)
Filing Information
| Accession Number | 0001104659-26-092867 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 8, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
2,165,708
Total Value
$10,200,000.00
P&L
+16.7% (+$1,704,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Aug 6, 2026 | Conversion | 782,854 | โ | โ | 782,854 | Indirect | See footnotes | View Details | |
10% Owner | Common Stock | โ | Aug 6, 2026 | Purchase | 200,000 | $17.00 | $3,400,000.00 | 982,854 | Direct | โ | View Details | |
10% Owner | Common Stock | โ | Aug 6, 2026 | Purchase | 400,000 | $17.00 | $6,800,000.00 | 1,182,854 | Indirect | See footnotes | View Details | |
10% Owner | Series B Preferred Stock | Derivative | Aug 6, 2026 | Conversion | 782,854 | โ | โ | 0 | Indirect | See footnotes | View Details |